477 related articles for article (PubMed ID: 11007651)
21. X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 A resolution.
Li de la Sierra I; Munier-Lehmann H; Gilles AM; Bârzu O; Delarue M
J Mol Biol; 2001 Aug; 311(1):87-100. PubMed ID: 11469859
[TBL] [Abstract][Full Text] [Related]
22. Catalysis and sulfa drug resistance in dihydropteroate synthase.
Yun MK; Wu Y; Li Z; Zhao Y; Waddell MB; Ferreira AM; Lee RE; Bashford D; White SW
Science; 2012 Mar; 335(6072):1110-4. PubMed ID: 22383850
[TBL] [Abstract][Full Text] [Related]
23. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
Giordanetto F; Fowler PW; Saqi M; Coveney PV
Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
[TBL] [Abstract][Full Text] [Related]
24. The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site.
LeMagueres P; Im H; Ebalunode J; Strych U; Benedik MJ; Briggs JM; Kohn H; Krause KL
Biochemistry; 2005 Feb; 44(5):1471-81. PubMed ID: 15683232
[TBL] [Abstract][Full Text] [Related]
25. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery.
Khedkar SA; Malde AK; Coutinho EC
J Mol Graph Model; 2005 Jan; 23(4):355-66. PubMed ID: 15670956
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
[TBL] [Abstract][Full Text] [Related]
27. The molecular structure of ornithine acetyltransferase from Mycobacterium tuberculosis bound to ornithine, a competitive inhibitor.
Sankaranarayanan R; Cherney MM; Garen C; Garen G; Niu C; Yuan M; James MN
J Mol Biol; 2010 Apr; 397(4):979-90. PubMed ID: 20184895
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of lumazine synthase from Mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors.
Morgunova E; Meining W; Illarionov B; Haase I; Jin G; Bacher A; Cushman M; Fischer M; Ladenstein R
Biochemistry; 2005 Mar; 44(8):2746-58. PubMed ID: 15723519
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.
Dennis ML; Chhabra S; Wang ZC; Debono A; Dolezal O; Newman J; Pitcher NP; Rahmani R; Cleary B; Barlow N; Hattarki M; Graham B; Peat TS; Baell JB; Swarbrick JD
J Med Chem; 2014 Nov; 57(22):9612-26. PubMed ID: 25357262
[TBL] [Abstract][Full Text] [Related]
30. Structure of the Mycobacterium tuberculosis flavin dependent thymidylate synthase (MtbThyX) at 2.0A resolution.
Sampathkumar P; Turley S; Ulmer JE; Rhie HG; Sibley CH; Hol WG
J Mol Biol; 2005 Oct; 352(5):1091-104. PubMed ID: 16139296
[TBL] [Abstract][Full Text] [Related]
31. Probing the roles of non-homologous insertions in the N-terminal domain of Plasmodium falciparum hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase.
Rattanachuen W; Jönsson M; Swedberg G; Sirawaraporn W
Mol Biochem Parasitol; 2009 Dec; 168(2):135-42. PubMed ID: 19631695
[TBL] [Abstract][Full Text] [Related]
32. The 1.9 A resolution structure of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a potential drug target.
Henriksson LM; Björkelid C; Mowbray SL; Unge T
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):807-13. PubMed ID: 16790937
[TBL] [Abstract][Full Text] [Related]
33. Folate synthesis in higher-plant mitochondria: coupling between the dihydropterin pyrophosphokinase and the dihydropteroate synthase activities.
Mouillon JM; Ravanel S; Douce R; Rébeillé F
Biochem J; 2002 Apr; 363(Pt 2):313-9. PubMed ID: 11931659
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis.
Cohen-Gonsaud M; Ducasse S; Hoh F; Zerbib D; Labesse G; Quemard A
J Mol Biol; 2002 Jul; 320(2):249-61. PubMed ID: 12079383
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the Mycobacterium tuberculosis dUTPase: insights into the catalytic mechanism.
Chan S; Segelke B; Lekin T; Krupka H; Cho US; Kim MY; So M; Kim CY; Naranjo CM; Rogers YC; Park MS; Waldo GS; Pashkov I; Cascio D; Perry JL; Sawaya MR
J Mol Biol; 2004 Aug; 341(2):503-17. PubMed ID: 15276840
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
[TBL] [Abstract][Full Text] [Related]
37. A flexible loop at the dimer interface is a part of the active site of the adjacent monomer of Escherichia coli orotate phosphoribosyltransferase.
Henriksen A; Aghajari N; Jensen KF; Gajhede M
Biochemistry; 1996 Mar; 35(12):3803-9. PubMed ID: 8620002
[TBL] [Abstract][Full Text] [Related]
38. The crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Synechocystis sp. at 1.54 A resolution and its relationship to other condensing enzymes.
Moche M; Dehesh K; Edwards P; Lindqvist Y
J Mol Biol; 2001 Jan; 305(3):491-503. PubMed ID: 11152607
[TBL] [Abstract][Full Text] [Related]
39. Class-Specific Monoclonal Antibodies and Dihydropteroate Synthase in Bioassays Used for the Detection of Sulfonamides: Structural Insights into Recognition Diversity.
Li C; Liang X; Wen K; Li Y; Zhang X; Ma M; Yu X; Yu W; Shen J; Wang Z
Anal Chem; 2019 Feb; 91(3):2392-2400. PubMed ID: 30580515
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
